CVS Health Reports First Quarter Results; Confirms 2017 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
- Oil prices settle at pre-Iran war levels as crude output grows
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Broadcom secures role as key Apple supplier with chip deal through 2031
CVS Health (CVS) PT Raised to $88 at Evercore ISI; Model Bent Not Broken
May 2, 2017 12:27 PM EDTEvercore ISI raised its price target on CVS Health (NYSE: CVS) to $88.00 (from $87.00) while maintaining a Outperform rating following Q1 results.
Analyst Ross Muken believes shares are down today amid a "buyers strike" and bears who are feeling more emboldened. Meanwhile,... More
CVS Health (CVS) Tops Q1 EPS by 7c; Confirms Guidance
May 2, 2017 6:57 AM EDTCVS Health (NYSE: CVS) reported Q1 EPS of $1.17, $0.07 better than the analyst estimate of $1.10. Revenue for the quarter came in at $44.5 billion versus the consensus estimate of $44.2 billion.
Net revenues increased 3.0% to $44.5 billionGAAP diluted EPS from continuing operations of $0.92; Adjusted EPS of... More